[Cautious about the indication expansion of intraocular refractive surgery].

Myopic refractive surgery has developed vigorously in China during the past 30 years, and the number of surgeries is increasing year by year. Since intraocular refractive surgery has a wide range of correction, no need to cut the corneal tissue and a stable visual quality, it has been gradually promoted in clinical practice. Specialists from the Optometry Group of Chinese Ophthalmological Society have given guidance on the ocular indications, age, diopters and other aspects for the posterior chamber intraocular lens implantation. In this article, the authors expound that intraocular refractive surgery should not be recommended for low and moderate myopic eyes, neither for some special occupations at present. The complications of intraocular refractive surgery and the countermeasures are also discussed. The authors also put forward the principles of customized myopic refractive surgery and emphasize that the clinicians should be more cautious about the diopter range selection, occupational need evaluation, individual differences and complications of intraocular refractive surgery. (Chin J Ophthalmol, 2020, 56: 89-92).

[HBXIP expression in gastric adenocarcinoma predicts poor prognosis].

Objective: To investigate the localization of HBXIP protein over-expression in gastric adenocarcinoma, and its prognostic significance. Methods: HBXIP localization was detected by immunofluorescence in AGS gastric cancer cell line, and by immunohistochemical staining in 97 gastric adenocarcinomas, 41 adjacent non-tumor tissues and 13 gastric adenoma tissues. Correlation between HBXIP expression and clinicopathological features of gastric cancer patients was evaluated by Chi-square and Fisher's exact tests. Overall survival rates were calculated using Kaplan-Meier method. Results: HBXIP was mainly expressed in the cytoplasm of gastric cancer. The positive and strongly positive expression rates of HBXIP protein in gastric cancers were 68.0% (66/97) and 49.5% (48/97) respectively, and were significantly higher than those in adjacent non-tumor tissues(48.8%, 20/41; 36.6%, 15/41) or gastric adenomas(2/13, 1/13; all P<0.05). HBXIP expression correlated significantly with tumor differentiation and lymph node status (P=0.007; 0.041). Kaplan-Meier survival analysis showed that the overall survival rate was significantly lower in gastric cancer patients with high HBXIP expression (P=0.015). Conclusions: HBXIP expression in gastric cancer is mainly expressed in cytoplasmic, and the expression level is closely related to the prognosis. HBXIP expression status may potentially be used as an important prognostic indicator for gastric cancer.